N-3 Fatty acids: Role in neurogenesis and neuroplasticity

Current Medicinal Chemistry

Volumn 20, Issue 24, 2013, Pages 2953-2963

  Crupi, R ^a   Marino, A ^b   Cuzzocrea, S ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Dentate gyrus; N 3 fatty acids; Neurogenesis; Synaptic plasticity

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 9 FATTY ACID; SATURATED FATTY ACID; SYNAPSIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BIPOLAR DISORDER; CEREBROVASCULAR ACCIDENT; COGNITION; CORPUS STRIATUM; DEPRESSION; DIET SUPPLEMENTATION; EGG; EVOLUTION; FISH; FOOD COMPOSITION; HUMAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; SCHIZOPHRENIA; SPINAL CORD INJURY; SYNAPTOGENESIS; TRAUMATIC BRAIN INJURY; VEGETABLE;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; ALZHEIMER DISEASE; ANIMALS; COGNITION; DENTATE GYRUS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; MODELS, ANIMAL; NEUROGENESIS; NEURONAL PLASTICITY; SCHIZOPHRENIA;

EID: 84880301389     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990140     Document Type: Article

References (105)

1. Fahy, E.; Subramaniam, S., Brown, H.A.; Glass, C.K.; Merrill, A.H. Jr.; Murphy, R,C.; Raetz, C.R.; Russell, D.W.; Seyama, Y.; Shaw, W. et al. A comprehensive classification system for lipids. J. Lipid Res., 2005, 46(5), 839-861.
2. Simopoulos, A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother., 2006, 60(9), 502-507.
3. Gomez Candela, C.; Bermejo Lopez, L.M.; Loria Kohen, V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp, 2011, 26(2), 323-329.
4. Sprecher, H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta, 2000, 1486(2-3), 219-231.
5. Nakamura, M.T.; Nara, T.Y.; Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukot. Essent. Fatty Acids., 2003, 68(2), 145-150.
6. Brenna, J.T. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care, 2002, 5(2), 127-132.
7. Simopoulos, A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp.Biol. Med. (Maywood), 2008, 233(6), 674-688.
8. Simopoulos, A.P. Human requirement for N-3 polyunsaturated fatty acids. Poult. Sci., 2000, 79(7), 961-970.
9. Lim, S.Y.; Suzuki, H. Effect of dietary docosahexaenoic acid and phosphatidylcholine on maze behavior and fatty acid composition of plasma and brain lipids in mice. Int. J. Vitam. Nutr. Res., 2000, 70(5), 251-259.
10. Eaton, S.B.; Konner, M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med., 1985, 312(5), 283-289.
11. Simopoulos, A.P.;, Norman, H.A. Gillaspy, J.E. Purslane in human nutrition and its potential for world agriculture. World Rev. Nutr. Diet.,1995, 77, 47-74.
12. Crawford, M.A. Stability of habitats in relation to food selection. Proc. R. Soc. Med., 1968, 61(2), 159.
13. Connor; W.E. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr., 2000, 71(1), 171S-175S.
14. Matsuoka, Y. Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder? Biopsychosoc. Med., 2011, 8, 5-3.
15. Orr, S,K.; Trepanier, M.O.; Bazinet, R.P.; n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot. Essent. Fatty Acids, 2012, [Epub ahead of print]
16. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L.; et al. Inflammation and Alzheimer's disease. Neurobiol. Agin, 2000, 21(3), 383-421.
17. Hashimoto, M.; Tozawa, R.; Katakura, M.; Shahdat, H.; Haque, A.M.; Tanabe, Y.; Gamoh, S.; Shido, O. Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid beta-infused rats. Food Funct., 2011, 2(7), 386-394.
18. Su, H.M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J. Nutr. Biochem., 2010, 21(5), 364-373.
19. Calon, F.; Cole, G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot. Essent. Fatty Acids, 2007, 77(5-6), 287-293.
20. Green, K.N.; Martinez-Coria, H.; Khashwji, H.; Hall, E.B,.; Yurko-Mauro, K.A.; Ellis, L.; LaFerla, F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci., 2007, 27(16), 4385-4395.
21. Minogue, A.M.; Lynch, A.M.; Loane, D.J.; Herron, C.E.; Lynch, M.A. Modulation of amyloid-beta-induced and age-Associated changes in rat hippocampus by eicosapentaenoic acid. J. Neurochem., 2007, 103(3), 914-926.
22. Hashimoto, M.; Hossain, S.; Tanabe, Y.; Kawashima, A.; Harada, T.; Yano, T.; Mizuguchi, K.; Shido, O. The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta (1-40). J. Nutr. Biochem.,2009, 20(12), 965-973.
23. Lukiw, W.J.; Bazan, N.G. Docosahexaenoic acid and the aging brain. J. Nutr., 2008, 138(12), 2510-2514.
24. Bate, C.; Marshall, V.; Colombo, L.; Diomede, L.; Salmona, M.; Williams, A. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. Neuropharmacology, 2008, 54(6), 934-943.
25. Chiu, C.C.; Su, K.P.; Cheng, T.C.; Liu, H.C.; Chang, C.J.; Dewey, M.E., Stewart, R.; Huang, S.Y. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol., 2008, 32(6), 1538-1544.
26. Chen, H.; Zhang, S.M.; Hernan, M.A.; Willett, W.C.; Ascherio, A. Dietary intakes of fat and risk of Parkinson's disease. Am. J. Epidemiol., 2003, 157(11), 1007-1014.
27. de Lau, L.M.; Bornebroek, M.; Witteman, J.C.; Hofman, A.; Koudstaal, P.J.; Breteler, M.M. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology,2005, 64(12), 2040-2045.
28. Bousquet, M.; Saint-Pierre, M.; Julien, C.; Salem, N. Jr.; Cicchetti, F.; Calon, F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J., 2008, 22(4), 1213-1225.
29. Riedel, M.; Goldbaum, O.; Wille, M.; Richter-Landsberg, C. Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of alpha-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. J. Mol. Neurosci., 2011, 43(3), 290-302.
30. Kaltschmidt, B.; Baeuerle, P.A.; Kaltschmidt, C. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects Med.,1993, 14(3), 171-190.
31. Blight, A.R. Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma, 1992, 9(1), S83-89.
32. Samadikuchaksaraei, A. An overview of tissue engineering approaches for management of spinal cord injuries. J. Neuroeng. Rehabil., 2007, 4, 15.
33. Lang-Lazdunski, L.; Blondeau, N.; Jarretou, G.; Lazdunski, M.; Heurteaux, C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg., 2003, 38(3), 564-575.
34. Ward, R.E.; Huang, W.; Curran, O.E.; Priestley, J.V.; Michael-Titus, A.T. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma, 2010, 27(10), 1769-1780.
35. Lim, S.N.; Huang, W.; Hall, J.C.; Ward, R.E., Priestley, J.V., Michael-Titus, A.T. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot. Essent. Fatty Acids, 2010, 83(4-6), 193-201.
36. Albensi, B.C. Models of brain injury and alterations in synaptic plasticity. J. Neurosci. Res., 2001, 65(4), 279-283.
37. Waxweiler, R.J.; Thurman, D.; Sniezek, J.; Sosin, D.; O'Neil, J. Monitoring the impact of traumatic brain injury: a review and update. J. Neurotrauma 1995, 12(4), 509-516.
38. Greve, M.W.; Zink, B.J. Pathophysiology of traumatic brain injury. Mt. Sinai J. Med., 2009, 76(2), 97-104.
39. Wu, A., Ying, Z.; Gomez-Pinilla, F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma, 2004, 21(10), 1457-1467.
40. Mills, J.D., Hadley, K.; Bailes, J.E. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery, 2011, 68(2), 474-481.
41. Lakhan, S.E.; Kirchgessner, A.; Hofer, M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med., 2009, 7, 97.
42. Belayev, L., Khoutorova, L.; Atkins, K.D.; Bazan, N.G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009, 40, 3121-3126.
43. Lauritzen, I., Blondeau, N.; Heurteaux, C., Widmann, C., Romey, G.; Lazdunski, M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J, 2000, 19(8), 1784-1793.
44. Strokin, M., Chechneva, O., Reymann, K.G.; Reiser, G. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience, 2006, 140(2), 547-553.
45. Freeman, M.P. Omega-3 fatty acids in psychiatry: a review. Ann. Clin. Psychiatry, 2000, 12(3), 159-165.
46. Haastrup, E., Knorr, U., Erikstrup, C., Kessing, L.V., Ullum, H. No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression. J. Neuroimmunol., 2012, 243(1-2), 69-72.
47. Bourre, J.M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2 : macronutrients. J. Nutr., 2006, 10(5), 386-399.
48. Song, C.; Zhao, S. Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations. Expert Opin. Investig. Drugs, 2007, 16(10), 1627-1638.
49. Peet, M., Brind, J., Ramchand, C.N., Shah, S., Vankar, G.K. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr. Res., 2001, 49(3), 243-251.
50. Rapoport, S.I.; Chang, M.C., Spector, A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res., 2001, 42(5), 678-685.
51. Sakamoto, T.; Cansev, M.; Wurtman, R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res., 2007, 1182, 50-59.
52. Blanpied, T.A.; Ehlers, M.D. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol. Psychiatry, 2004, 55(12), 1121-1127.
53. Dyall, S.C., Michael, G.J., Whelpton, R., Scott, A.G., Michael-Titus, A.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiology of aging 2007, 28(3), 424-439.
54. Calon. F., Lim, G.P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A.; Salem. N., Jr., Ashe, K.H. et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron, 2004, 43(5) 633-645.
55. Nemets, H., Nemets, B., Apter, A., Bracha, Z., Belmaker, R.H. Omega-3 treatment of childhood depression: a controlled, doubleblind pilot study. Am. J. Psychiatry, 2006, 163(6), 1098-1100.
56. Jacobs, B.L.; Adult brain neurogenesis and depression. Brain Behav. Immun., 2002, 16(5), 602-609.
57. Bremner, J.D., Narayan, M.; Anderson, E.R., Staib, L.H., Miller, H.L., Charney, D.S.; Hippocampal volume reduction in major depression. Am. J. Psychiatry, 2000, 157(1), 115-118.
58. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N., Manji, H.K. Enhancement of hippocampal neurogenesis by lithium. J. neurochem., 2000, 75(4), 1729-1734.
59. Gould, E., Tanapat, P., McEwen, B.S.; Flugge, G., Fuchs, E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. U S A., 1998, 95(6), 3168-3171.
60. Hibbeln, J.R. Fish consumption and major depression. Lancet, 1998, 351(9110), 1213.
61. Peet, M.; M.B., Shay, J.; Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry, 1998, 43(5), 315-319.
62. Maes, M. S.R., Christophe, A., Cosyns, P.; Desnyder, R.; Meltzer, H.; Fatty acid composition in major depression: decreased omega-3 fractions idn cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord., 1996, 38(1), 35-46.
63. Hibbeln, J.R.; Umhau, J.C.; Linnoila, M.; George, D.T.; Ragan, P.W.; Shoaf, S.E. Vaugham, M.R.; Rawlings, R.; Salem, N. Jr. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol. Psychiatry, 1998, 44(4), 243- 249.
64. Song, C.; Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G. Bosman, E.; Sharpe, S.; Whelan, A.; Cosyns, P.; de Jongh, R.; Maes, M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J. Affect. Disord., 1998, 49(3), 211-219.
65. Kelly, V.E., Ferretti, A.; Izui, S., Strom, T.B. A fish oil diet rich in eicosapentanoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MPL-1pr mice. J. Immunol., 1985, 134(3), 1914-1919.
66. J.E.; K. Lipids, membrane receptors, and enzymes: Effects of dietary fatty acids. J. Parenter. Enteral. Nutr.,1990, 14(5), 200s-217s.
67. Stoll, A.L.; Severeus, W.E.; Freeman, M.P.; Rueter, S.; Zboyan, H.A.; Diamond, E. Cress, K.K.; Marangell, L.B. Omega-3 fatty acids in bipolar disorder: a double-blind placebo-controlled trial. Arch. Gen. Psychiatry, 1999, 56(5), 407-412.
68. Peet, M.; Laugharne, J.D.; Mellor, J.; Ramchand, C.N. Essential fatty acid deficiency in erythrocyte membranes from chronicschizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot. Essent. Fatty Acids, 1996, 55(1-2), 71-75.
69. Sahay, A.; Hen, R. Adult hippocampal neurogenesis in depression. Nat. Neurosci., 2007, 10(9), 1110-1115.
70. Beltz, B.S.; Sandeman, D.C. Regulation of life-long neurogenesis in the decapod crustacean brain. Arthropod. Struct. Dev., 2003, 32(1), 39-60.
71. Harzsch, S., Miller, J.; Benton, J., Beltz, B. From embryo to adult: persistent neurogenesis and apoptotic cell death shape the lobster deutocerebrum. J Neurosci., 1999, 19(9), 3472-3485.
72. Beltz, B.S., Tlusty, M.F., Benton, J.L.; Sandeman, D.C., Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett., 2007, 415(2), 154-158.
73. Coti Bertrand, P.; O'Kusky, J.R.; Innis, S.M. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J. Nutr., 2006, 136(6), 1570-1575.
74. He, C., Qu, X.; Cui, L.; Wang, J.; Kang, J.X. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. U S A., 2009, 106(27), 11370-11375.
75. Kawakita, E.; Hashimoto, M.; Shido, O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience, 2006, 139(3), 991-997.
76. Wang, P.Y.; Chen, J.J.; Su, H.M. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and upregulates cytoskeletal protein expression. J. Nutr. Biochem., 2010, 21(4), 345-350.
77. Kim, H.Y.; Akbar, M., Lau, A.; Edsall, L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem., 2000, 275(45), 35215-35223.
78. Green, P.; Glozman, S.; Kamensky, B.; Yavin, E. Developmental changes in rat brain membrane lipids and fatty acids. The preferential prenatal accumulation of docosahexaenoic acid. J. Lipid Res., 1999, 40(5), 960-966.
79. Yamashima, T. A putative link of PUFA, GPR40 and adult-born hippocampal neurons for memory. Progr Neurobiol 2008, 84(2), 105-115.
80. Kan, I.; Melamed, E.; Offen, D.; Green, P. Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. J. Lipid Res., 2007, 48(3), 513-517.
81. Shrivastava, R.; Vincent, B.; Gobron, S.; Cucuat, N.; John, G.W. Evidence for growth-promoting effects of omega n -3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells. Nutritional neurosci., 2005, 8(5-6), 317-321.
82. Cao D, Kevala K, Kim J, Moon HS, Jun SB, Lovinger D, Kim HY: Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem., 2009, 111(2), 510-521.
83. Futerman, A.H., Banker, G.A. The economics of neurite outgrowth-the addition of new membrane to growing axons. Trends Neurosci., 1996, 19(4), 144-149.
84. Youdim, K.A., Martin, A., Joseph, J.A. Essential fatty acids and the brain: possible health implications. Int. J. Dev. Neurosci., 2000, 18(4-5), 383-399.
85. Bhatia, H.S., Agrawal, R.; Sharma, S., Huo, Y.X., Ying, Z., Gomez-Pinilla, F. Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PloS one, 2011, 6(12), e28451.
86. Oertner, T.G., Matus, A. Calcium regulation of actin dynamics in dendritic spines. Cell calcium, 2005, 37(5), 477-482.
87. Yorek, M.; Leeney, E., Dunlap, J.; Ginsberg, B.; Effect of fatty acid composition on insulin and IGF-I binding in retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 1989, 30(10), 2087-2092.
88. Fukaya, T.; Gondaira, T.; Kashiyae, Y.; Kotani, S.; Ishikura, Y.; Fujikawa, S.; Kiso, Y.; Sakakibara, M. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol. Aging, 2007, 28(8), 1179-1186.
89. McGahon, B.M.; Martin, D.S.; Horrobin, D.F.; Lynch, M.A. Agerelated changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol. Aging, 1999, 20(6), 655-664.
90. Deneris, E.S. Molecular genetics of mouse serotonin neurons across the lifespan. Neuroscience, 2011, 197, 17-27.
91. Shahbakhti, H.; Watson, R.E.; Azurdia, R.M.; Ferreira, C.Z.; Garmyn, M.; Rhodes, L.E. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-Alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem. photobiol., 2004, 80(2), 231-235.
92. Wada, T.; Shimba, S.; Tezuka, M. Transcriptional regulation of the hypoxia inducible factor-2alpha (HIF-2alpha) gene during adipose differentiation in 3T3-L1 cells. Biol. Pharma Bull., 2006, 29(1), 49-54.
93. Venna, V.R.; Deplanque, D.; Allet, C.; Belarbi, K.; Hamdane, M.; Bordet, R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34(2), 199-211.
94. Alonso M, Medina JH, Pozzo-Miller L: ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Lear. Mem., 2004, 11(2), 172-178.
95. Crupi, R.; Cambiaghi, M.; Deckelbaum, R.; Hansen, I.; Mindes, J.; Spina, E.; Battaglia, F. n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell activating factor (BAFF) transgenic mice. Prev. Med., 2012, 54, S103-108.
96. Kashiyae, Y.; Kontani, M.; Kawashima, H.; Kiso, Y.; Kudo, Y.; Sakakibara, M. Arachidonic acid enhances intracellular calcium levels in dentate gyrus, but not CA1, in aged rat. Neurosci.Res., 2009, 64(2), 143-151.
97. Chalon, S.; Vancassel, S.; Zimmer, L.; Guilloteau, D.; Durand, G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids, 2001, 36(9), 937-944.
98. Fujita, S.; Ikegaya, Y.; Nishikawa, M.; Nishiyama, N.; Matsuki, N. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br. J. Pharmacol., 2001, 132(7), 1417-1422.
99. Tanabe, Y.; Hashimoto, M.; Sugioka, K.; Maruyama, M.; Fujii, Y.; Hagiwara, R.; Hara, T.; Hossain, S.M.; Shido, O. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin. Exp. Pharmacol. Physiol., 2004, 31(10), 700-703.
100. Cansev, M.; Wurtman, R.J.; Sakamoto, T.; Ulus, I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement, 2008, 4(1), S153-168.
101. McGahon, B.M.; Martin, D.S.; Horrobin, D.F., Lynch, M.A. Agerelated changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience, 1999, 94(1), 305-314.
102. Cline, H.T. Dendritic arbor development and synaptogenesis. Curr. Opin. Neurobiol., 2001, 11, 118-126.
103. Kerchner, G.A.; Nicoll, R.A. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat. Rev., 2008, 9(11), 813-825.
104. Grosshans, D.R.; Clayton, D.A.; Coultrap, S.J.; Browning, M.D. LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nat. Neurosci., 2002, 5(1), 27-33.
105. Baldelli, P.; Fassio, A.; Valtorta, F.; Benfenati F. Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J. Neurosci., 2007, 27(49), 13520-13531.